<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02260323</url>
  </required_header>
  <id_info>
    <org_study_id>CT20141003</org_study_id>
    <nct_id>NCT02260323</nct_id>
  </id_info>
  <brief_title>Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chengdu PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic
      rheumatic disease
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from baseline in HBCS(Hill-Bone Compliance Scale) score at 48 weeks</measure>
    <time_frame>at 0 week, 12 weeks, 24 weeks, 48 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in MARS(Medication Adherence Rating Scale) score at 48 weeks</measure>
    <time_frame>at 0 week, 12 weeks, 24 weeks, 48 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chronic Rheumatic Diseases</condition>
  <arm_group>
    <arm_group_label>patient-tailored anti-arthritis herbs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient use tailored anti-arthritis herbs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patient-tailored DMARDs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients use tailored DMARDs</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patient-tailored anti-arthritis herbs</intervention_name>
    <description>patient use tailored anti-arthritis herbs</description>
    <arm_group_label>patient-tailored anti-arthritis herbs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patient-tailored DMARDs</intervention_name>
    <description>patient use tailored disease-modifying antirheumatic drugs</description>
    <arm_group_label>patient-tailored DMARDs</arm_group_label>
    <other_name>patient-tailored disease-modifying antirheumatic drugs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  were between 18 and 35 years of age

          -  without use of TCM in the previous 3 months

          -  and had a Steinbrocker functional status of class I, II, or III

        Exclusion Criteria:

          -  previous general health conditions disallowed their use of TCM

          -  were pregnant

          -  lack of motivation, remote from home, time-consuming,intervention, or other personal
             difficulties
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>General Hospital of Chengdu Military Area Command PLA</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610083</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>October 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2014</study_first_posted>
  <last_update_submitted>March 31, 2017</last_update_submitted>
  <last_update_submitted_qc>March 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chengdu PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yang Min</investigator_full_name>
    <investigator_title>Ph.D</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antirheumatic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

